Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21890210 | 0.90 | KDM4E (0.43) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL22223073 | 0.88 | KDM4E (0.45) | KDM4EATML3MBTL1KDRALDH1A1 | |
| SCHEMBL21890469 | 0.88 | KDM4E (0.45) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL19651035 | 0.87 | L3MBTL1 (0.49) | KDM4EATML3MBTL1KDRMEN1 | |
| SCHEMBL21890473 | 0.87 | L3MBTL1 (0.56) | KDM4EATML3MBTL1KDRMEN1 | |
| SCHEMBL19651098 | 0.87 | L3MBTL1 (0.56) | KDM4EATML3MBTL1KDRMEN1 | |
| SCHEMBL19651100 | 0.85 | KDM4E (0.43) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL21890846 | 0.84 | L3MBTL1 (0.53) | KDM4EATML3MBTL1KDRMEN1 | |
| SCHEMBL19651078 | 0.84 | L3MBTL1 (0.53) | KDM4EATML3MBTL1KDRMEN1 | |
| SCHEMBL21890222 | 0.84 | KDM4E (0.36) | KDM4EATML3MBTL1ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230068759-A1 | DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2023-03-02 | — | — | US | disclosed |
| US-20200227656-A1 | DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2020-07-16 | — | — | US | disclosed |
| US-10615349-B2 | Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-F]phenanthridine and analogues | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2020-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200227656-A1 | DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES | SUN2, STAU1, HELZ | KDM4E 4206/4885ATM 3709/4885L3MBTL1 1232/4885 |
| US-20230068759-A1 | DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES | SUN2, STAU1, HELZ | KDM4E 4206/4885ATM 3709/4885L3MBTL1 1232/4885 |
| US-10615349-B2 | Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-F]phenanthridine and analogues | SUN2, STAU1, HELZ | KDM4E 4206/4885ATM 3709/4885L3MBTL1 1232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.